Reliance Chemotex Industries DuPont analysis

Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
1.07×1.09×1.11×0.57×0.74×
0.20×0.19×0.21×0.27×0.68×
7.1%7.2%4.9%5.7%6.7%
0.73×0.73×0.75×0.84×1.00×
3.59×3.59×3.46×3.60×3.01×
4.0%3.8%2.9%2.6%10.2%
3.8%3.8%3.0%2.4%9.8%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

RELCHEMQ₹109.52

Reliance Chemotex Industries Limited

· Textiles
₹ CrorePeersFIBERWEBSELMCNAGREEKEXPBHANDARIDIGJAMLMTDPIONEEREMBLOYALTEXSURYALAXMIMcap ₹82.6 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.740.571.111.091.07
Interest Burden (Pretax/EBIT) ×0.680.270.210.190.20
EBIT Margin %6.715.704.917.167.06
Asset Turnover ×1.000.840.750.730.73
Financial Leverage (Assets/Equity) ×3.013.603.463.593.59
ROE (5-step product, year-end total equity) %10.242.642.923.813.95
ROE (owners' profit / average owners' equity) %9.802.422.993.763.76
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.